Molbio Diagnostics IPO — IPO Calculators
Lot size, investment, listing gain, allotment probability & grey market calculators
Lot & Investment Calculator
Find out how much to invest based on lots
Listing Gain Calculator
Estimate your profit or loss at listing
GMP-based: ₹937
Calculated on retail lot size of 18 shares at issue price ₹807. Actual returns may vary.
Allotment Probability
Estimated chance of getting allotment by category
Subscription data not yet available.
Check back after the IPO subscription opens.
Probability is indicative only. SEBI mandates a computerised lottery for retail applicants when oversubscribed.
Grey Market Calculator
Kostak rate & Subject to Sauda profit estimator
Kostak is income received per application in the grey market, regardless of allotment outcome. It is an informal market and carries risk.
Break-even Calculator
Minimum listing price to not make a loss
Disclaimer: All calculations are indicative and for educational purposes only. GMP data is unofficial and sourced from grey market channels. Allotment probability is a statistical estimate based on subscription data and does not guarantee allotment. Do not make investment decisions solely based on these calculators.
Frequently Asked Questions
How much is the minimum investment for Molbio Diagnostics IPO IPO?
The minimum investment for Molbio Diagnostics IPO IPO is ₹14,526 for 1 lot of 18 shares at ₹807 per share (cutoff/upper band price).
How does the Lot Size Calculator work?
The lot size calculator multiplies your chosen number of lots by the shares per lot and the issue price to give the total investment required. It automatically enforces the minimum and maximum lot limits set by SEBI for each investor category.
How is listing gain calculated?
Listing Gain = (Expected Listing Price − Issue Price) × Shares per Lot × Lots Allotted. For Molbio Diagnostics IPO, the issue price is ₹807. Our calculator pre-fills the expected listing price using the current GMP estimate.
What is Kostak rate and Subject to Sauda?
Kostak is a fixed premium paid per application in the grey market, whether or not you get allotment. Subject to Sauda (STS) is paid per lot only if allotment is received. Both are part of India's informal IPO grey market and carry financial risk.
How accurate is the allotment probability shown?
The allotment probability is a statistical estimate based on the subscription multiplier. SEBI mandates a computerised lottery for retail applicants in oversubscribed IPOs, so actual outcomes vary. Applying from multiple accounts with separate PANs is illegal.